𝔖 Bobbio Scriptorium
✦   LIBER   ✦

On the performance of some aromaticity indices: A critical assessment using a test set

✍ Scribed by Ferran Feixas; Eduard Matito; Jordi Poater; Miquel Solà


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
247 KB
Volume
29
Category
Article
ISSN
0192-8651

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Aromaticity is a central chemical concept widely used in modern chemistry for the interpretation of molecular structure, stability, reactivity, and magnetic properties of many compounds. As such, its reliable prediction is an important task of computational chemistry. In recent years, many methods to quantify aromaticity based on different physicochemical properties of molecules have been proposed. However, the nonobservable nature of aromaticity makes difficult to assess the performance of the numerous existing indices. In the present work, we introduce a series of fifteen aromaticity tests that can be used to analyze the advantages and drawbacks of a group of aromaticity descriptors. On the basis of the results obtained for a set of ten indicators of aromaticity, we conclude that indices based on the study of electron delocalization in aromatic species are the most accurate among those examined in this work. © 2008 Wiley Periodicals, Inc. J Comput Chem, 2008


📜 SIMILAR VOLUMES


A critical review of the assessment of e
✍ Michael York; Winfried Steiling 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Traditionally, the eye irritation potential of substances and products has been assessed using the Draize eye test. While this procedure has been criticized in terms of its scientific validity and its ethical acceptability, it remains the only official, government-recognized procedure for predicting

A critical assessment of the ICH guideli
✍ Steven W. Baertschi; Karen M. Alsante; Hanne H. Tønnesen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

The ICH guideline on photostability (ICH Topic Q1B) was published in November 1996 and has been implemented in all three regions (US, EU, and Japan). The guideline describes a useful basic protocol for testing of new drug substances and associated drug products for manufacturing, storage, and distri